TTC24 inhibitors refer to a class of chemical compounds that specifically target and inhibit the activity of TTC24, a protein characterized by the presence of tetratricopeptide repeat (TPR) domains. These domains are structural motifs involved in mediating protein-protein interactions, commonly found in various regulatory and scaffolding proteins. TTC24, in particular, plays a role in the cellular processes of protein complex assembly and regulation of intracellular signaling pathways. TTC24 inhibitors are designed to interfere with the function of this protein, often by binding to its active sites or TPR motifs, which are crucial for its interaction with other cellular proteins. By inhibiting TTC24, these compounds can modulate specific biochemical pathways where TTC24 is a key mediator, leading to changes in cellular function and signaling.
Structurally, TTC24 inhibitors are often small molecules engineered with high specificity for the TTC24 protein. These compounds may have a range of molecular features, such as hydrophobic groups or hydrogen bond donors and acceptors, that enable them to bind effectively to TTC24. The chemical design of these inhibitors often focuses on achieving selectivity, ensuring minimal interaction with other TPR-containing proteins in the cell. This specificity is critical for studying TTC24's biological role in detail. The exploration of TTC24 inhibitors also provides a deeper understanding of the structural biology of the TPR domain, revealing how subtle changes in the binding interface can influence the inhibitor's affinity and potency.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
A Hsp90 inhibitor that could potentially destabilize proteins requiring Hsp90 for folding or function, indirectly affecting proteins associated with TTC24. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that could increase the levels of proteins by preventing their degradation, possibly affecting TTC24-related proteins. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
An inhibitor of eukaryotic protein synthesis, potentially reducing the synthesis of TTC24 and its associated proteins by inhibiting mRNA translation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that could influence gene expression patterns, possibly affecting the expression of genes encoding TTC24 or its interacting partners. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could alter gene expression, potentially impacting TTC24 expression or the expression of related signaling molecules. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
A steroidal lactone that has been shown to disrupt protein-protein interactions, potentially affecting complexes involving TTC24. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $175.00 $600.00 $1179.00 $5100.00 $9180.00 | 26 | |
An ATP synthase inhibitor, affecting cellular energy metabolism, which could indirectly impact protein functions associated with TTC24. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor similar to MG132 but with clinical usage, potentially affecting the degradation pathway of TTC24-related proteins. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
Another Hsp90 inhibitor, similar to Geldanamycin, which could destabilize client proteins of Hsp90, indirectly affecting TTC24-associated proteins. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
An antibiotic that inhibits protein synthesis, potentially reducing TTC24 protein levels or those of associated proteins by prematurely terminating translation. |